Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
AgeNot listed
SponsorSanta Chiara Hospital
About this trial
This is an observational, retrospective/prospective, multicenter study designed to define, overall survival, clinical outcomes and predictive/prognostic factors of a consecutive population of mCRPC patients treated with olaparib in clinical practice.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Olaparib
Treatment groups
3,000 Participants
are divided into 1 treatment groupLocations
2Sabrina Rossetti Naples Italy
Orazio Caffo Trento Italy
Sponsors and collaborators
Santa Chiara Hospital
Lead sponsor
Source ClinicalTrials.gov